rs1554338260
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM5BS2
The NM_002047.4(GARS1):c.1000A>G(p.Ile334Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I334F) has been classified as Pathogenic.
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1000A>G | p.Ile334Val | missense_variant | Exon 8 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1000A>G | p.Ile334Val | missense_variant | Exon 8 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.898A>G | p.Ile300Val | missense_variant | Exon 7 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.832A>G | p.Ile278Val | missense_variant | Exon 9 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.799A>G | p.Ile267Val | missense_variant | Exon 8 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.631A>G | p.Ile211Val | missense_variant | Exon 8 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.631A>G | p.Ile211Val | missense_variant | Exon 9 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.1000A>G | non_coding_transcript_exon_variant | Exon 8 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*714A>G | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.1000A>G | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*338A>G | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.1000A>G | non_coding_transcript_exon_variant | Exon 8 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*870A>G | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.1000A>G | non_coding_transcript_exon_variant | Exon 8 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*942A>G | non_coding_transcript_exon_variant | Exon 10 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.1000A>G | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*451A>G | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*289A>G | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*432A>G | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1000A>G | non_coding_transcript_exon_variant | Exon 8 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*714A>G | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674737.1 | n.*338A>G | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000675529.1 | n.*870A>G | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*942A>G | 3_prime_UTR_variant | Exon 10 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676164.1 | n.*451A>G | 3_prime_UTR_variant | Exon 8 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*289A>G | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*432A>G | 3_prime_UTR_variant | Exon 8 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461844Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727226
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Ile334 amino acid residue in GARS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17101916, 24604904, 25168514). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1063149). This variant has not been reported in the literature in individuals affected with GARS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 334 of the GARS protein (p.Ile334Val). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at